MHC class II genotype and the control of viremia in HIV-1–infected individuals on highly active antiretroviral therapy
AUTOR(ES)
Blankson, Joel N.
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=199437Documentos Relacionados
- Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy
- Lipid profile of HIV-1 infected patients under highly active antiretroviral therapy
- Response of HIV-associated proteinuria to antiretroviral therapy in HIV-1-infected children
- Assessment of cytokine values in serum by RT-PCR in HIV-1 infected individuals with and without highly active anti-retroviral therapy (HAART)
- Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study